EU regulator probes swine flu vaccine over narcolepsy fears

Aug 27, 2010

The European Medicines Agency said Friday it was probing whether there is a link between the Pandemrix swine flu vaccine and the sleeping disorder narcolepsy amid concerns in Finland and Sweden.

"The European Medicines Agency has launched a review of Pandemrix on the request of the European Commission to investigate whether there is a link between cases of narcolepsy and vaccination with Pandemrix," the EMA said.

"A limited number of cases was reported, all collected through spontaneous reporting systems, mainly in Sweden and Finland," the London-based agency added in a statement.

Finland's National Institute for Health and Welfare on Tuesday recommended halting the use of Pandemrix until a probe into a possible link to narcolepsy among children is concluded.

Last week, neighbouring Sweden's Medical Products Agency also opened an inquiry into the Pandemrix following reports of young people having developed symptoms consistent with narcolepsy after getting their shot.

Narcolepsy is a condition in which sufferers suddenly fall into a deep sleep.

"Its precise cause is unknown, but it is generally considered to be triggered by a combination of genetic and environmental factors, including infections," the EMA said.

It added that Pandemrix -- produced by British pharmaceutical company GlaxoSmithKline -- has been used since September 2009 for vaccination against H1N1 for at least 30.8 million Europeans.

Explore further: India's meth addiction grows as criminals tap chemical hub

add to favorites email to friend print save as pdf

Related Stories

Sweden opens inquiry into suspect flu vaccine

Aug 18, 2010

Sweden's Medical Products Agency opened an inquiry Wednesday into vaccinations for swine flu made by British pharmaceutical company GlaxoSmithKline, suspected of provoking narcolepsy.

EU drug agency: License 2 swine flu vaccines

Sep 25, 2009

(AP) -- The European Union's drug regulator recommended Friday that two swine flu vaccines be licensed in the 27-nation bloc to ensure their availability before the start of the normal flu season.

WHO: nearly 5,000 swine flu deaths worldwide

Oct 23, 2009

(AP) -- Nearly 5,000 people have reportedly died from swine flu since it emerged this year and developed into a global epidemic, the World Health Organization said Friday.

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments : 0